Cherry Creek Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History
Cherry Creek Investment Advisors, Inc.
- $187 Million
- Q1 2025
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 10,363 shares of BMY stock, worth $517,839. This represents 0.34% of its overall portfolio holdings.
Number of Shares
10,363
Previous 10,266
0.94%
Holding current value
$517,839
Previous $580,000
8.97%
% of portfolio
0.34%
Previous 0.3%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,811Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.56 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.93 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.4 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.74 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.32 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...